Literature DB >> 8346115

Linear IgA bullous dermatosis in a neonate.

L L Hruza1, S B Mallory, J Fitzgibbons, G B Mallory.   

Abstract

A newborn black boy had two facial blisters at birth that progressed to bullous lesions over the trunk, genitals, extremities, and oral and tracheal mucosa. A biopsy specimen demonstrated a subepidermal bulla with mixed eosinophilic and neutrophilic, inflammatory infiltrate. Direct immunofluorescence showed linear IgA, IgG, and C3 depositions along the basement membrane zone, consistent with a diagnosis of childhood linear IgA bullous dermatosis (chronic bullous dermatosis of childhood). The skin disease was controlled with combined prednisone and dapsone. This is the youngest reported patient with the disease. Linear IgA bullous dermatosis should be considered in the differential diagnosis of blistering diseases of the newborn, and immunofluorescence should be performed on a skin biopsy specimen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346115     DOI: 10.1111/j.1525-1470.1993.tb00049.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Linear IgA bullous dermatosis in tunisian children: 31 cases.

Authors:  Kharfi Monia; Khaled Aida; Karaa Amel; Zaraa Ines; Fazaa Becima; Kamoun Mohamed Ridha
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

2.  Linear IGA bullous dermatosis potentially triggered by vaccination.

Authors:  Alberto Corrà; Veronica Bonciolini; Lavinia Quintarelli; Alice Verdelli; Marzia Caproni
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

Review 3.  Linear Immunoglobulin a Bullous Dermatosis in Children.

Authors:  Francesca Mori; Francesca Saretta; Lucia Liotti; Mattia Giovannini; Riccardo Castagnoli; Stefania Arasi; Simona Barni; Carla Mastrorilli; Luca Pecoraro; Lucia Caminiti; Gian Luigi Marseglia; Annick Barbaud; Elio Novembre
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.